Although it has been used for prostate cancer detection since its first day of clinical use, PSA is an organ-specific not a disease specific marker and it can be measured high in all diseases (acute or chronic prostatitis, urinary retention) or interventions (prostatic manipulations, urinary catheterization) affecting the prostate. Here, KLK3 is linked to prostate carcinoma.